Intérêt de la cystatine C pour l'adaptation de posologie des médicaments anticancéreux à élimination rénale
Thérapie, 62 2 (2007) 121-127
Published online: 2007-06-23
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed
N. de Rouw, R. Beunders, O. Hartmann, J. Schulte, R. J. Boosman, H. J. Derijks, D. M. Burger, M. M. van den Heuvel, L. B. Hilbrands, P. Pickkers and R. ter HeineCancer Chemotherapy and Pharmacology 94 (6) 799 (2024)
https://doi.org/10.1007/s00280-024-04717-w
Traditions and innovations in assessment of glomerular filtration rate using creatinine to cystatin C
Maria Clarissa Tio, Tariq Shafi, Xiaoqian Zhu, Kamyar Kalantar-Zadeh, Alexandre Chan and Lee NguyenCurrent Opinion in Nephrology & Hypertension 32 (1) 89 (2023)
https://doi.org/10.1097/MNH.0000000000000854
Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review
Erin F. Barreto, Andrew D. Rule, M. Hassan Murad, Kianoush B. Kashani, John C. Lieske, Patricia J. Erwin, James M. Steckelberg, Ognjen Gajic, Joel M. Reid and Sandra L. Kane-GillMayo Clinic Proceedings 94 (3) 500 (2019)
https://doi.org/10.1016/j.mayocp.2018.08.002
Innovative Use of Novel Biomarkers to Improve the Safety of Renally Eliminated and Nephrotoxic Medications
Erin F. Barreto, Andrew D. Rule, Stacy A. Voils and Sandra L. Kane‐GillPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (8) 794 (2018)
https://doi.org/10.1002/phar.2149